{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:22:44Z","timestamp":1790688164757,"version":"4.1.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"Supplement_3","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Pakistan has a high hepatitis burden for both hepatitis C virus (HCV) and hepatitis B virus (HBV). To achieve World Health Organization (WHO) 2030 targets for hepatitis elimination, there is a need to constitute progress in the country, find the barriers and strategies for HCV elimination, and take actions to address the gaps.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We collected data from (1) WHO estimates in 2020, (2) midterm review questionnaire of the WHO regional action plan, and (3) WHO estimates on immunization. We analyzed these data to inform (1) the burden defined as prevalence and mortality and (2) response in 3 thematic areas: governance, policy, and finance; strategic information; and service delivery.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The prevalence of hepatitis B in the general population is 1.6% with 12 000 deaths\/year. The prevalence of hepatitis C in the general population is 7.5% with 19 000 deaths and 545 000 new cases (incidence)\/year. The selected indicators to monitor progress on viral hepatitis in Pakistan were governance and financing, policies and guidelines, and strategic information. The overall governance indicators are good with a focal point, a national hepatitis strategy, an operational plan, strategy for price reduction, and involvement of civil society but the costed action plan and the advocacy strategy are missing. The indicators on policies and guidelines are also adequately addressed. The hepatitis B and C testing and treatment guidelines are available, there is a policy to screen all blood donations, and there is an injection safety policy, but the policy for timely hepatitis B vaccine birth dose and hepatitis B vaccination for the vulnerable is missing. Both indicators regarding strategic information, that is measures of key hepatitis indicators and regular data review, are missing. The status of 5 key interventions in Pakistan show that the hepatitis B vaccination coverage is 74% and only 3% of newborn children are given the hepatitis B vaccine birth dose. Only 22% of HCV cases have been diagnosed and 2% have received treatment. Treatment response is 96%. Same-day testing and treatment of hepatitis C reduced the overall dropout rate and improved the cascade of care. Decentralization and task shifting are important tools to improve service delivery and reach communities. Finances to implement hepatitis elimination is a major barrier.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Pakistan has the highest hepatitis disease burden. With the current pace, hepatitis elimination appears impossible. Introduction of the birth dose of hepatitis B vaccine and improving access and affordability of testing can improve the testing and treatment numbers. Finances need to be mobilized from within the country and outside to support disease elimination.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiad022","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T19:41:32Z","timestamp":1674762092000},"page":"S204-S210","source":"Crossref","is-referenced-by-count":13,"title":["Barriers and Strategies for Hepatitis B and C Elimination in Pakistan"],"prefix":"10.1093","volume":"228","author":[{"given":"Huma","family":"Qureshi","sequence":"first","affiliation":[{"name":"Gastroenterologist and National Focal Point Hepatitis, Hepatitis Control, Ministry of National Health Services , Regulations and Coordination, Islamabad , Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Mahmood","sequence":"additional","affiliation":[{"name":"In-Charge Hepatitis Planning, Development and Monitoring Unit, USAID Funded GHSC PSM Project seconded at Ministry of Health, Hepatitis Control, Ministry of National Health Services , Regulations and Coordination, Islamabad , Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Sabry","sequence":"additional","affiliation":[{"name":"Universal Health Coverage\/Department of Communicable Disease Prevention and Control, World Health Organization Regional Office for the Eastern Mediterranean , Cairo , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joumana","family":"Hermez","sequence":"additional","affiliation":[{"name":"Universal Health Coverage\/Department of Communicable Disease Prevention and Control, World Health Organization Regional Office for the Eastern Mediterranean , Cairo , Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"key":"2023091316595965200_jiad022-B1","author":"World Health Organization","year":"2016"},{"key":"2023091316595965200_jiad022-B2","author":"World Health Organization","year":"2017"},{"key":"2023091316595965200_jiad022-B3","volume-title":"Regional action plan for the implementation of the global strategy for viral hepatitis 2017\u20132021","author":"World Health Organization Regional Office for the Eastern Mediterranean","year":"2016"},{"key":"2023091316595965200_jiad022-B4","volume-title":"National hepatitis strategic framework (NHSF) for Pakistan 2017\u201321","author":"Pakistan Health Research Council (PHRC)","year":"2021"},{"key":"2023091316595965200_jiad022-B5","volume-title":"Provincial hepatitis action plans for Punjab and Sindh 2019\u201320","author":"Pakistan Health Research Council"},{"key":"2023091316595965200_jiad022-B6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S2468-1253(22)00082-6","article-title":"Progress towards elimination of viral hepatitis by 2030 in the WHO Eastern Mediterranean Region, 2019","volume":"7","author":"Sabry","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2023091316595965200_jiad022-B7","author":"World Health Organization","year":"2017"},{"key":"2023091316595965200_jiad022-B8","author":"World Health Organization"},{"key":"2023091316595965200_jiad022-B9","volume-title":"Final report\u2014population based prevalence survey of hepatitis B&C Punjab, 2018","author":"APEX Consulting","year":"2019"},{"key":"2023091316595965200_jiad022-B10","volume-title":"Sindh serosurvey report 2020 WHO regional office Pakistan","author":"Qureshi"},{"key":"2023091316595965200_jiad022-B11","volume-title":"HCV Health Policy Tool\u2014Pakistan. Final assumptions\/inputs and scenarios Center for Data Analysis USA","year":"2021"},{"key":"2023091316595965200_jiad022-B12","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J Hepatol"},{"key":"2023091316595965200_jiad022-B13","author":"World Health Organization","year":"2016"},{"key":"2023091316595965200_jiad022-B14","year":"2021","journal-title":"National guidelines for the treatment of persons with chronic hepatitis C infection,"},{"key":"2023091316595965200_jiad022-B15","year":"2022","journal-title":"National hepatitis B treatment guidelines 2022. WHO country office."},{"key":"2023091316595965200_jiad022-B16","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.138020"},{"key":"2023091316595965200_jiad022-B17","author":"Chaudhry","year":"2020"},{"key":"2023091316595965200_jiad022-B18","article-title":"A model screen test and treat hepatitis C elimination project among underserved communities in Islamabad -the federal capital of Pakistan","author":"Qureshi","year":"2022"},{"key":"2023091316595965200_jiad022-B19","article-title":"Free screening testing and treatment of HCV in high-risk population (police force) in Islamabad","author":"Qureshi","year":"2022"},{"key":"2023091316595965200_jiad022-B20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0041-1731110","article-title":"A systematic review and meta-analysis on the epidemiology of hepatitis B and hepatitis C virus among beta-thalassemia major patients in Pakistan","volume":"13","author":"Waheed","year":"2021","journal-title":"J Lab Physicians"},{"key":"2023091316595965200_jiad022-B21","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.3201\/eid2704.204205","article-title":"Systematic review of reported HIV outbreaks, Pakistan, 2000\u20132019","volume":"27","author":"Rabold","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2023091316595965200_jiad022-B22"},{"key":"2023091316595965200_jiad022-B23"},{"key":"2023091316595965200_jiad022-B24","author":"Nai Nindagi Trust"},{"key":"2023091316595965200_jiad022-B25","author":"The Global Fund"},{"key":"2023091316595965200_jiad022-B26","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.26719\/2010.16.Supp.15","article-title":"Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures","volume":"16","author":"Qureshi","year":"2010","journal-title":"East Mediterr Health J"},{"key":"2023091316595965200_jiad022-B27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1186\/s12913-019-4366-9","article-title":"Injection practices in 2011\u20132015: a review using data from the demographic and health surveys (DHS)","volume":"19","author":"Hayashi","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"2023091316595965200_jiad022-B28","first-page":"1149","article-title":"Comparison of need and supply of syringes for therapeutic injections in Pakistan","volume":"62","author":"Ahmed","year":"2012","journal-title":"J Pak Med Assoc"},{"key":"2023091316595965200_jiad022-B29","first-page":"1068","article-title":"A third major human immunodeficiency viruses (HIV) outbreak in Larkana, Pakistan: caused by unsafe injection practices","volume":"69","author":"Altaf","year":"2019","journal-title":"J Pak Med Assoc"},{"key":"2023091316595965200_jiad022-B30","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1473-3099(19)30743-1","article-title":"HIV Infection predominantly affecting children in Sindh, Pakistan, 2019: a cross sectional study of an outbreak","volume":"20","author":"Mir","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"2023091316595965200_jiad022-B31","doi-asserted-by":"crossref","first-page":"e440","DOI":"10.1016\/S2214-109X(20)30003-6","article-title":"Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis","volume":"8","author":"Lim","year":"2020","journal-title":"Lancet Glob Health"},{"key":"2023091316595965200_jiad022-B32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/ije\/dyx270","article-title":"Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination","volume":"47","author":"Lim","year":"2018","journal-title":"Int J Epidemiol"},{"key":"2023091316595965200_jiad022-B33"},{"key":"2023091316595965200_jiad022-B34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.3613","article-title":"Assessment of the feasibility and cost of hepatitis C elimination in Pakistan","volume":"2","author":"Chhatwal","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2023091316595965200_jiad022-B35","author":"Ministry of Health"},{"key":"2023091316595965200_jiad022-B36","author":"World Health Organization","year":"2020"},{"key":"2023091316595965200_jiad022-B37","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1056\/NEJMsr1912628","article-title":"Screening and treatment program to eliminate hepatitis C in Egypt","volume":"382","author":"Waked","year":"2020","journal-title":"N Engl J Med"},{"key":"2023091316595965200_jiad022-B38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jhepr.2019.04.002","article-title":"Global progress on the elimination of viral hepatitis as a major public health threat: an analysis of WHO member state responses 2017","volume":"1","author":"Smith","year":"2019","journal-title":"JHEP Rep"},{"key":"2023091316595965200_jiad022-B39","author":"World Health Organization"},{"key":"2023091316595965200_jiad022-B40","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/14787210.2020.1758065","article-title":"Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt","volume":"18","author":"Esmat","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2023091316595965200_jiad022-B41","doi-asserted-by":"crossref","first-page":"e431","DOI":"10.1016\/S2214-109X(20)30505-2","article-title":"Decentralisation, integration, and task shifting in hepatitis C virus infection testing and treatment: a global systemic review and meta-analysis","volume":"9","author":"Oru","year":"2021","journal-title":"Lancet Global Health"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/Supplement_3\/S204\/51544047\/jiad022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/Supplement_3\/S204\/51544047\/jiad022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T17:00:38Z","timestamp":1694624438000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/228\/Supplement_3\/S204\/7273016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":41,"journal-issue":{"issue":"Supplement_3","published-online":{"date-parts":[[2023,9,13]]},"published-print":{"date-parts":[[2023,9,13]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad022","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,9,15]]},"published":{"date-parts":[[2023,9,13]]}}}